# Beam Therapeutics Inc. (BEAM)

> Healthcare · US · Reports in USD

Fundamental indicators from Sponda, adjusted for inflation.

[HTML version](https://sponda.capital/en/BEAM/fundamentals)

## Annual figures

| Year | Revenue (M) | Net Inc. (M) | FCF (M) | Debt (M) | Equity (M) |
| --- | --- | --- | --- | --- | --- |
| 2026 | $ 32.23M | $ -217.00M | $ -199.26M | $ 247.36M | $ 1.07B |
| 2025 | $ 143.08M | $ -81.90M | $ -368.66M | $ 293.88M | $ 1.24B |
| 2024 | $ 66.76M | $ -395.99M | $ -374.39M | $ 161.43M | $ 733.55M |
| 2023 | $ 408.40M | $ -143.30M | $ -197.79M | $ 172.69M | $ 981.33M |
| 2022 | $ 68.05M | $ -322.94M | $ -29.52M | $ 179.01M | $ 733.47M |
| 2021 | $ 61.62M | $ -440.56M | $ -134.41M | $ 147.64M | $ 826.74M |
| 2020 | $ 30.6K | $ -247.90M | $ -142.80M | $ 107.64M | $ 245.56M |
| 2019 | $ 23.2K | $ -101.10M | $ -109.10M | $ 31.24M | $ 100.95M |
| 2018 | $ 0 | $ -152.22M | $ -44.14M | $ 0 | $ 134.03M |

Columns not available in this view: annualPriceMultiples, dividends. They require live market data and are shown on the HTML page instead.

## Leverage and liquidity

| Indicator | Value |
| --- | --- |
| Gross Debt / Eq | 0.23 |
| Liabilities / Eq | 0.30 |
| Current Ratio | 14.57 |

## Other views

- [Metrics](https://sponda.capital/en/BEAM.md)
- [Charts](https://sponda.capital/en/BEAM/charts.md)
- [Compare](https://sponda.capital/en/BEAM/compare.md)
- [Indicator definitions](https://sponda.capital/en/screener.md)

Data as of 2026-08-27.